A detailed history of Tilia Fiduciary Partners, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Tilia Fiduciary Partners, Inc. holds 1,244 shares of AMGN stock, worth $327,395. This represents 0.28% of its overall portfolio holdings.

Number of Shares
1,244
Previous 1,205 3.24%
Holding current value
$327,395
Previous $376,000 6.38%
% of portfolio
0.28%
Previous 0.3%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$309.38 - $337.38 $12,065 - $13,157
39 Added 3.24%
1,244 $400,000
Q2 2024

Jul 11, 2024

SELL
$262.75 - $319.31 $12,349 - $15,007
-47 Reduced 3.75%
1,205 $376,000
Q1 2024

Apr 12, 2024

BUY
$268.87 - $324.56 $537 - $649
2 Added 0.16%
1,252 $355,000
Q4 2023

Jan 12, 2024

SELL
$255.7 - $288.46 $1,278 - $1,442
-5 Reduced 0.4%
1,250 $360,000
Q3 2023

Oct 10, 2023

BUY
$218.65 - $271.46 $22,520 - $27,960
103 Added 8.94%
1,255 $337,000
Q2 2023

Jul 13, 2023

SELL
$214.27 - $253.37 $5,999 - $7,094
-28 Reduced 2.37%
1,152 $255,000
Q1 2023

May 10, 2023

BUY
$225.79 - $275.2 $677 - $825
3 Added 0.25%
1,180 $285,000
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $458 - $582
2 Added 0.17%
1,177 $309,000
Q3 2022

Oct 26, 2022

BUY
$224.46 - $253.15 $448 - $506
2 Added 0.17%
1,175 $288,000
Q2 2022

Aug 01, 2022

BUY
$230.71 - $256.74 $24,224 - $26,957
105 Added 9.83%
1,173 $290,000
Q1 2022

Apr 18, 2022

BUY
$219.27 - $242.57 $438 - $485
2 Added 0.19%
1,068 $258,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $212,006 - $242,621
1,066 New
1,066 $240,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tilia Fiduciary Partners, Inc. Portfolio

Follow Tilia Fiduciary Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tilia Fiduciary Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tilia Fiduciary Partners, Inc. with notifications on news.